Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KRYS

Krystal Biotech Inc

Jun 11 • 04:00PM ET

321.55

+9.14 2.92 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM IONS ALNY INCY MDGL NUVL VKTX UTHR PCRX

| Held by: IJR VTI IWM VB XBI FBT VBK VXF SPSM IJT

Scroll to Statements

Index	RUT	P/E	42.98	EPS (ttm)	7.48	Insider Own	12.56%	Shs Outstand	29.44M	Perf Week	4.47%
Market Cap	9.48B	Forward P/E	33.11	EPS next Y	9.71	Insider Trans	-5.24%	Shs Float	25.78M	Perf Month	3.62%
Enterprise Value	8.66B	PEG	1.43	EPS next Q	1.79	Inst Own	96.01%	Short Float	12.21%	Perf Quarter	27.95%
Income	225.03M	P/S	22.72	EPS this Y	13.33%	Inst Trans	-1.27%	Short Ratio	11.07	Perf Half Y	37.04%
Sales	417.30M	P/B	7.41	EPS next Y	25.28%	ROA	18.21%	Short Interest	3.15M	Perf YTD	30.42%
Book/sh	43.37	P/C	11.51	EPS next 5Y	23.11%	ROE	19.90%	52W High	320.32 0.38%	Perf Year	130.30%
Cash/sh	27.93	P/FCF	39.93	EPS past 3/5Y	- -	ROIC	17.53%	52W Low	127.99 151.23%	Perf 3Y	149.41%
Dividend Est.	-	EV/EBITDA	46.77	Sales past 3/5Y	- -	Gross Margin	92.72%	Volatility	3.45% 3.59%	Perf 5Y	394.30%
Dividend TTM	-	EV/Sales	20.76	EPS Y/Y TTM	79.56%	Oper. Margin	42.81%	ATR (14)	11.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.06	Sales Y/Y TTM	25.15%	Profit Margin	53.92%	RSI (14)	64.59	Recom	1.17
Dividend Gr. 3/5Y	- -	Current Ratio	9.46	EPS Q/Q	53.27%	SMA20	5.61%	Beta	0.52	Target Price	330.56
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	31.95%	SMA50	11.99%	Rel Volume	1.70	Prev Close	312.41
Employees	295	LT Debt/Eq	0.01	Earnings	May 04 BMO	SMA200	34.19%	Avg Volume	284.35K	Price	321.55
IPO	Sep 20, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.80% 3.79%	Trades		Volume	477,350	Change	2.92%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)